In the last year there have been significant changes at the PTAB that every IP practitioner should be aware of – the full impact of the Arthrex decision, ongoing questions about discretionary denials, and the future direction of IPRs.
American Conference Institute’s (ACI) virtual PTAB Practice Briefing on December 2nd will provide in-depth discussions and year-end analysis of these most significant developments impacting PTAB practice as well as future forecasts for 2022. CLE Credits are available.
The conference will be co-chaired by: Terry Rea (Crowell and Moring LLP) and Steve Baughman (Paul, Weiss, Rifkind, Wharton & Garrison LLP.) Presenters include Naveen Modi (Paul Hastings LLP), Joseph Matal (Haynes and Boone LLP), Karl Renner (Fish & Richardson), Sara Tonnies Horton (Willkie Farr & Gallagher LLP), and Ken Korea (Colev Law), Prominent APJs and counsel from United Patents, Eisai, Medtronic, Dell, Microsoft, Eisai, BASF, and Xperi will also present at this important year-end IP event.
Benefit from year-end analyses and future forecasts on the most significant developments impacting post-grant proceedings.
- Arthrex and the constitutionality of APJ appointments
- The appointment of the New PTO Director
- Ongoing questions about discretionary denials
- The future direction of IPRs
Full information on the briefing can be found here.
About American Conference Institute:
A unique organization, American Conference Institute is devoted to providing the business intelligence that senior decision-makers need to respond to challenges both here in the US, and around the world.
Staffed by industry specialists, lawyers and other professionals, American Conference Institute operates as a think-tank, monitoring trends and developments in all major industry sectors, the law, and public policy, with a view to providing information on the leading edge.